Company / Cash per Share
Caris Life Sciences, Inc. Cash per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$21.81
FY2025
5-year range
$21.81 / $21.81
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#15 of 147
Health Care
What the data says
Among 147 Health Care companies, Caris Life Sciences, Inc. is in the top 10% for cash per share.
Based on SEC 10-K filings.
21.81 in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 147This company $21.81 Sector average $27.42
▼
-20.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.81 | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026